From gatekeeper to strategic partner:
How early quality involvement drives better decisions and reduces risk


Marta Rodríguez Vélez,
Head of Corporate Quality in LETI Pharma

As pharmaceutical organizations adopt AI, digital solutions, and advanced manufacturing technologies, quality can no longer be brought in after key decisions have been made. In this session, Marta will explore how early quality involvement helps reduce risk, strengthen compliance, and improve project outcomes. Drawing on real-world examples, she will share how quality teams can evolve from reviewers to strategic partners, supporting innovation through expertise in patient safety, quality, and risk management.

 

In this session you will learn:

  • How early quality involvement helps prevent compliance gaps, validation challenges, and costly project delays.
  • Where quality can add value in AI, digitalization, and automation projects from the start.
  • How to anticipate risks and support better project decisions.
  • The skills and mindset needed to make quality a strategic contributor to innovation.

 

You’ll leave with a clear understanding of how to involve quality early in technology projects, anticipate risks, and build the skills and partnerships needed to drive innovation.